Minh-ha Do
Director of Pre-Clinical Innovation
Molecular Biology
Lumos Pharma
Netherlands
Biography
Minh-Ha Do is Director of Pre-Clinical Innovation at Lumos Pharma. Dr. Do previously played dual roles as Program Scientific Lead and Associate Director of Physiology at a biotechnology company called aTyr Pharma. There, she was responsible for defining the scientific strategy to drive multiple drug development projects from discovery phase into early clinical development. Her functional roles included oversight of pre-clinical pharmacology, pharmacokinetics and toxicology and she represented these functions in interactions with the FDA and other regulatory agencies. She worked on therapeutics for cancer and rare hematopoietic and inflammatory diseases.
Research Interest
Molecular Biology
